Jeremy M. Levin
| This article is a stub. You can help by expanding it. |
Contents
Biographical Information
Dr. Jeremy M. Levin, DPhil, MB, BChir, became President and Chief Executive Officer of Teva Pharmaceutical Industries Ltd. on May 9, 2012.
FRom 2008: "Dr. Jeremy Levin has joined BMS's Research and Development organization as senior vice president, External Science, Technology and Licensing, on October 2007. Prior to joining Bristol-Myers Squibb, Dr. Levin served as Global Head of Business Development and Strategic Alliances at the Novartis Institutes of Biomedical Research. In that capacity, he and his team secured hundreds of collaborations in more than 20 countries since 2003. Prior to his tenure at Novartis, Dr. Levin held leadership positions in several biotechnology companies, including Physiome Sciences, Inc. and Cadus Pharmaceutical Corporation. He also was managing director of Perseus Capital LLC, a life sciences venture fund. He has served on the executive committees and boards of several public biosciences companies, as well as the Executive Committee of BIO and the boards of the Biotechnology Institute and the New York Biotechnology Association."[1]
His brother is David Levin.
Affiliations
Resources and articles
Related Sourcewatch
References
- ↑ biomedmanagement Jeremy M. Levin, organizational web page, accessed January 13, 2013.
